Skip to main content

Table 2 Adverse events occurring more than once or in more than one patient

From: An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod

System organ class
Preferred term
Mild (%) Moderate (%) Severe (%) Total (%)
Gastrointestinal disorders
 Diarrhea 2 (22)a    2 (22)a
Infections and infestations
 Nasopharyngitis 2 (22)    2 (22)
Musculoskeletal and connective tissue disorders
 Arthralgia 3 (33)b    3 (33)b
 Arthritis   2 (22)   2 (22)
 Myalgia 1 (11)a 1 (11)a   2 (22)a
Nervous system disorders
 Headache 3 (33)b    3 (33)b
  1. aRelated adverse events
  2. bTwo out of 3 related adverse events